CONTINUE TO SITE ➞

Don't miss tomorrow's biopharma industry news

Let BioPharma Dive's free newsletter keep you informed, straight from your inbox.

Daily Dive M-F

Commercialization Weekly Every Wednesday

Gene Therapy Weekly Every Thursday

Emerging Biotech Weekly Every Tuesday

By signing up to receive our newsletter, you agree to our Terms of Use and Privacy Policy. You can unsubscribe at anytime.

Deep Dive
Library
Events
Press Releases

Pharma
Biotech
FDA
Clinical Trials
Deals
Drug Pricing
Gene Therapy

What We're Reading: Page 356

Industry reads hand-picked by our editors

Jul 07, 2015

Seeking Alpha
Allergan nabs rights to Merck's investigational migraine meds for $250M
Biz Journals
Patient successfully lobbies firm to reveal whether or not she was on placebo in trial
Economic Times
Indian gov't to crack down on protocol violations in clinical trials
Marketplace
23andMe believes genetics are the future of health

Jul 06, 2015

Vox
US has 1st measles death since 2003
Forbes
A perfect blood test for pancreatic cancer?
Reuters
Swiss right-to-die group gets green light for new 'suicide room'

Jul 02, 2015

Reuters
Manufacturing deal wins China cheap supply of Glaxo's new HIV drug
Bloomberg
Celgene's $138,000 doc payment left off study disclosures
Reuters
Attorneys seek to challenge CA's new mandatory vax law

Jul 01, 2015

Fortune
NY set to award licenses to medical marijuana firms
Reuters
Novartis to test new pricing model with heart failure drug
Biz Journals
U of Pitt to lead antibiotics overuse study

Jun 30, 2015

PMLiVE
Merck plans expanded filing for Emend this year
USA Today
Senators, health experts demand action to address biolab accidents
Reuters
Mandatory vaccination bill heads to California governor's desk

Jun 29, 2015

Reuters
Egalet says its painkiller less likely to be abused
WSJ
Why gene-editing tech has scientists excited
Reuters
Vitae-Boehringer diabetes drug flops as add-on therapy

Jun 26, 2015

Reuters
Celladon may liquidate as it suspends gene therapy development
FierceBiotech
Alexion gets EU green light for pair of rare disease drugs
RAPS
Roche still resisting Avastin use for wet AMD

Previous Next

Get the free newsletter

Subscribe to BioPharma Dive for top news, trends & analysis

Email:

Select Newsletter: Daily Dive M-F
Select Newsletter: Commercialization Weekly Every Wednesday
Select Newsletter: Gene Therapy Weekly Every Thursday
Select Newsletter: Emerging Biotech Weekly Every Tuesday
Select user consent: By signing up to receive our newsletter, you agree to our Terms of Use and Privacy Policy. You can unsubscribe at anytime.

A valid email address is required. Please select at least one newsletter.

Library resources

Trendline
The state of drug pricing in 2024 Supported by GoodRx
Trendline
The latest developments in oncology research Supported by EVERSANA
Webinar - on demand
Biomanufacturing: Scale-up vs Scale-out Economics Custom content for Cytiva

View all

Company Announcements

View all | Post a press release

Events

View all | Promote an event

Industry Intel

Evolving Regulatory Landscape for Model Informed Drug Development (MIDD): Impact of the Draft ICH M15 Guidance Webinar - on demand • Provided by Certara
4 major trends shaping today’s oncology market Webinar - on demand • Provided by Advisory Board
Top Ways that AI Will Change Life Sciences Webinar - on demand • Provided by Salesforce

Explore

About
Editorial Team
Contact Us
Newsletter
Purchase Licensing Rights
Press Releases
What We're Reading

Reach our audience

Advertising
Post a press release
Promote an event

Related Publications

Healthcare Dive
MedTech Dive

Industry Dive is an Informa TechTarget business.

This website is owned and operated by Informa TechTarget, part of a global network that informs, influences and connects the world's technology buyers and sellers. All copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. TechTarget, Inc.'s registered office is 275 Grove St. Newton, MA 02466.

Home
- Pharma
- Biotech
- FDA
- Clinical Trials
- Deals
- Drug Pricing
- Gene Therapy
Deep Dive
Library
Events
Press Releases

Get BioPharma Dive in your inbox

The free newsletter covering the top industry headlines

Email:

Select Newsletter: Daily Dive M-F
Select Newsletter: Commercialization Weekly Every Wednesday
Select Newsletter: Gene Therapy Weekly Every Thursday
Select Newsletter: Emerging Biotech Weekly Every Tuesday
Select user consent: By signing up to receive our newsletter, you agree to our Terms of Use and Privacy Policy. You can unsubscribe at anytime.

A valid email address is required. Please select at least one newsletter.